nodes	percent_of_prediction	percent_of_DWPC	metapath
Asenapine—ADRA2A—type 2 diabetes mellitus	0.105	0.325	CbGaD
Asenapine—HTR2C—type 2 diabetes mellitus	0.0969	0.299	CbGaD
Asenapine—CYP1A2—type 2 diabetes mellitus	0.0731	0.226	CbGaD
Asenapine—CYP3A4—type 2 diabetes mellitus	0.0484	0.15	CbGaD
Asenapine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0295	0.0699	CbGbCtD
Asenapine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0287	0.068	CbGbCtD
Asenapine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0259	0.0613	CbGbCtD
Asenapine—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0236	0.0559	CbGbCtD
Asenapine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0231	0.0547	CbGbCtD
Asenapine—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0227	0.0536	CbGbCtD
Asenapine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0214	0.0505	CbGbCtD
Asenapine—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0206	0.0487	CbGbCtD
Asenapine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0206	0.0487	CbGbCtD
Asenapine—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0195	0.0462	CbGbCtD
Asenapine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0177	0.042	CbGbCtD
Asenapine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0151	0.0356	CbGbCtD
Asenapine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0142	0.0336	CbGbCtD
Asenapine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0136	0.0321	CbGbCtD
Asenapine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0136	0.0321	CbGbCtD
Asenapine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.013	0.0308	CbGbCtD
Asenapine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0296	CbGbCtD
Asenapine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00736	0.0174	CbGbCtD
Asenapine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00657	0.0155	CbGbCtD
Asenapine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00648	0.0153	CbGbCtD
Asenapine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00606	0.0143	CbGbCtD
Asenapine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00579	0.0137	CbGbCtD
Asenapine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00578	0.0137	CbGbCtD
Asenapine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00548	0.013	CbGbCtD
Asenapine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00529	0.0125	CbGbCtD
Asenapine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00498	0.0118	CbGbCtD
Asenapine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00477	0.0113	CbGbCtD
Asenapine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00462	0.0109	CbGbCtD
Asenapine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00418	0.00989	CbGbCtD
Asenapine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00373	0.00884	CbGbCtD
Asenapine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00317	0.00749	CbGbCtD
Asenapine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00304	0.00718	CbGbCtD
Asenapine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00304	0.00718	CbGbCtD
Asenapine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00287	0.00679	CbGbCtD
Asenapine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00214	0.00506	CbGbCtD
Asenapine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00196	0.00463	CbGbCtD
Asenapine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00192	0.0715	CbGeAlD
Asenapine—HTR2A—arteriole—type 2 diabetes mellitus	0.00188	0.07	CbGeAlD
Asenapine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00129	0.0481	CbGeAlD
Asenapine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0012	0.0446	CbGeAlD
Asenapine—DRD1—nerve—type 2 diabetes mellitus	0.00116	0.0433	CbGeAlD
Asenapine—HTR1B—artery—type 2 diabetes mellitus	0.000948	0.0354	CbGeAlD
Asenapine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.000931	0.0347	CbGeAlD
Asenapine—HTR1D—artery—type 2 diabetes mellitus	0.000918	0.0342	CbGeAlD
Asenapine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000804	0.03	CbGeAlD
Asenapine—UGT1A4—kidney—type 2 diabetes mellitus	0.00078	0.0291	CbGeAlD
Asenapine—HTR2A—hindlimb—type 2 diabetes mellitus	0.000744	0.0277	CbGeAlD
Asenapine—HTR7—artery—type 2 diabetes mellitus	0.000731	0.0273	CbGeAlD
Asenapine—HTR7—nerve—type 2 diabetes mellitus	0.000726	0.027	CbGeAlD
Asenapine—DRD2—nerve—type 2 diabetes mellitus	0.000686	0.0256	CbGeAlD
Asenapine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.000683	0.0254	CbGeAlD
Asenapine—HTR7—endothelium—type 2 diabetes mellitus	0.000618	0.023	CbGeAlD
Asenapine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00058	0.0216	CbGeAlD
Asenapine—HRH2—cardiovascular system—type 2 diabetes mellitus	0.0005	0.0186	CbGeAlD
Asenapine—UGT1A4—liver—type 2 diabetes mellitus	0.000493	0.0184	CbGeAlD
Asenapine—HTR2A—artery—type 2 diabetes mellitus	0.000456	0.017	CbGeAlD
Asenapine—HTR2A—nerve—type 2 diabetes mellitus	0.000452	0.0169	CbGeAlD
Asenapine—HTR2A—endothelium—type 2 diabetes mellitus	0.000385	0.0144	CbGeAlD
Asenapine—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.00033	0.0123	CbGeAlD
Asenapine—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000319	0.0119	CbGeAlD
Asenapine—HTR1D—kidney—type 2 diabetes mellitus	0.000312	0.0116	CbGeAlD
Asenapine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00031	0.0116	CbGeAlD
Asenapine—HRH2—liver—type 2 diabetes mellitus	0.000309	0.0115	CbGeAlD
Asenapine—Amoxapine—ADRA2A—type 2 diabetes mellitus	0.000302	0.292	CrCbGaD
Asenapine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000297	0.0111	CbGeAlD
Asenapine—DRD2—retina—type 2 diabetes mellitus	0.000284	0.0106	CbGeAlD
Asenapine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000283	0.0105	CbGeAlD
Asenapine—Amoxapine—HTR2C—type 2 diabetes mellitus	0.000278	0.269	CrCbGaD
Asenapine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000273	0.0102	CbGeAlD
Asenapine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000266	0.00991	CbGeAlD
Asenapine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000262	0.00976	CbGeAlD
Asenapine—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.00026	0.0097	CbGeAlD
Asenapine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000258	0.00961	CbGeAlD
Asenapine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000254	0.00947	CbGeAlD
Asenapine—HTR7—kidney—type 2 diabetes mellitus	0.000249	0.00927	CbGeAlD
Asenapine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000245	0.00914	CbGeAlD
Asenapine—Loxapine—ADRA2A—type 2 diabetes mellitus	0.000235	0.228	CrCbGaD
Asenapine—ADRA2C—kidney—type 2 diabetes mellitus	0.000229	0.00852	CbGeAlD
Asenapine—ADRA2C—pancreas—type 2 diabetes mellitus	0.000227	0.00846	CbGeAlD
Asenapine—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000223	0.0083	CbGeAlD
Asenapine—Loxapine—HTR2C—type 2 diabetes mellitus	0.000217	0.21	CrCbGaD
Asenapine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000216	0.00806	CbGeAlD
Asenapine—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000206	0.00768	CbGeAlD
Asenapine—HTR2A—retina—type 2 diabetes mellitus	0.000187	0.00698	CbGeAlD
Asenapine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000181	0.00675	CbGeAlD
Asenapine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000178	0.00662	CbGeAlD
Asenapine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000167	0.00624	CbGeAlD
Asenapine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000164	0.00613	CbGeAlD
Asenapine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000159	0.00591	CbGeAlD
Asenapine—HTR7—liver—type 2 diabetes mellitus	0.000157	0.00586	CbGeAlD
Asenapine—HTR2A—kidney—type 2 diabetes mellitus	0.000155	0.00578	CbGeAlD
Asenapine—ADRA1A—liver—type 2 diabetes mellitus	0.000152	0.00565	CbGeAlD
Asenapine—ADRA2C—liver—type 2 diabetes mellitus	0.000144	0.00539	CbGeAlD
Asenapine—CYP3A4—kidney—type 2 diabetes mellitus	0.000144	0.00535	CbGeAlD
Asenapine—CYP2D6—kidney—type 2 diabetes mellitus	0.000141	0.00527	CbGeAlD
Asenapine—CYP1A2—liver—type 2 diabetes mellitus	0.000125	0.00467	CbGeAlD
Asenapine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000111	0.000897	CcSEcCtD
Asenapine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000111	0.000893	CcSEcCtD
Asenapine—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.000893	CcSEcCtD
Asenapine—Malaise—Orlistat—type 2 diabetes mellitus	0.000111	0.000892	CcSEcCtD
Asenapine—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000111	0.000891	CcSEcCtD
Asenapine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00011	0.000885	CcSEcCtD
Asenapine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00011	0.000884	CcSEcCtD
Asenapine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00011	0.000883	CcSEcCtD
Asenapine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000109	0.000882	CcSEcCtD
Asenapine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000109	0.00088	CcSEcCtD
Asenapine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000109	0.000876	CcSEcCtD
Asenapine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000108	0.000873	CcSEcCtD
Asenapine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000108	0.000872	CcSEcCtD
Asenapine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000108	0.000872	CcSEcCtD
Asenapine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000871	CcSEcCtD
Asenapine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000108	0.000868	CcSEcCtD
Asenapine—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000107	0.000866	CcSEcCtD
Asenapine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000107	0.000862	CcSEcCtD
Asenapine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000107	0.00086	CcSEcCtD
Asenapine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000107	0.000859	CcSEcCtD
Asenapine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000106	0.000857	CcSEcCtD
Asenapine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000106	0.000855	CcSEcCtD
Asenapine—Tremor—Metformin—type 2 diabetes mellitus	0.000106	0.000854	CcSEcCtD
Asenapine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000106	0.000852	CcSEcCtD
Asenapine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000106	0.000851	CcSEcCtD
Asenapine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000105	0.000849	CcSEcCtD
Asenapine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000105	0.000844	CcSEcCtD
Asenapine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000842	CcSEcCtD
Asenapine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000104	0.00084	CcSEcCtD
Asenapine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000104	0.000839	CcSEcCtD
Asenapine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000103	0.000833	CcSEcCtD
Asenapine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000103	0.000831	CcSEcCtD
Asenapine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000103	0.000829	CcSEcCtD
Asenapine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000103	0.000827	CcSEcCtD
Asenapine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000102	0.000824	CcSEcCtD
Asenapine—Malaise—Metformin—type 2 diabetes mellitus	0.000102	0.000822	CcSEcCtD
Asenapine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000102	0.000818	CcSEcCtD
Asenapine—Syncope—Metformin—type 2 diabetes mellitus	0.000101	0.000818	CcSEcCtD
Asenapine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000101	0.000817	CcSEcCtD
Asenapine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000101	0.000815	CcSEcCtD
Asenapine—Rash—Glipizide—type 2 diabetes mellitus	0.000101	0.000811	CcSEcCtD
Asenapine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000101	0.000811	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000101	0.00081	CcSEcCtD
Asenapine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.0001	0.000807	CcSEcCtD
Asenapine—Headache—Glipizide—type 2 diabetes mellitus	0.0001	0.000806	CcSEcCtD
Asenapine—Tremor—Irbesartan—type 2 diabetes mellitus	0.0001	0.000806	CcSEcCtD
Asenapine—Insomnia—Gliclazide—type 2 diabetes mellitus	9.98e-05	0.000804	CcSEcCtD
Asenapine—Shock—Valsartan—type 2 diabetes mellitus	9.98e-05	0.000804	CcSEcCtD
Asenapine—Loss of consciousness—Metformin—type 2 diabetes mellitus	9.94e-05	0.000801	CcSEcCtD
Asenapine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	9.94e-05	0.000801	CcSEcCtD
Asenapine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	9.93e-05	0.0008	CcSEcCtD
Asenapine—Anaemia—Irbesartan—type 2 diabetes mellitus	9.87e-05	0.000795	CcSEcCtD
Asenapine—Dizziness—Glimepiride—type 2 diabetes mellitus	9.85e-05	0.000794	CcSEcCtD
Asenapine—Dysgeusia—Losartan—type 2 diabetes mellitus	9.84e-05	0.000793	CcSEcCtD
Asenapine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	9.84e-05	0.000793	CcSEcCtD
Asenapine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000792	CcSEcCtD
Asenapine—Dizziness—Sitagliptin—type 2 diabetes mellitus	9.82e-05	0.000792	CcSEcCtD
Asenapine—Agitation—Irbesartan—type 2 diabetes mellitus	9.81e-05	0.000791	CcSEcCtD
Asenapine—Somnolence—Gliclazide—type 2 diabetes mellitus	9.81e-05	0.000791	CcSEcCtD
Asenapine—HTR2A—liver—type 2 diabetes mellitus	9.8e-05	0.00365	CbGeAlD
Asenapine—Hypertension—Metformin—type 2 diabetes mellitus	9.77e-05	0.000787	CcSEcCtD
Asenapine—Angioedema—Irbesartan—type 2 diabetes mellitus	9.76e-05	0.000786	CcSEcCtD
Asenapine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000786	CcSEcCtD
Asenapine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000784	CcSEcCtD
Asenapine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	9.71e-05	0.000783	CcSEcCtD
Asenapine—Muscle spasms—Losartan—type 2 diabetes mellitus	9.66e-05	0.000778	CcSEcCtD
Asenapine—Asthenia—Bromocriptine—type 2 diabetes mellitus	9.65e-05	0.000777	CcSEcCtD
Asenapine—Malaise—Irbesartan—type 2 diabetes mellitus	9.63e-05	0.000776	CcSEcCtD
Asenapine—Headache—Pioglitazone—type 2 diabetes mellitus	9.58e-05	0.000772	CcSEcCtD
Asenapine—Syncope—Irbesartan—type 2 diabetes mellitus	9.57e-05	0.000771	CcSEcCtD
Asenapine—Leukopenia—Irbesartan—type 2 diabetes mellitus	9.56e-05	0.00077	CcSEcCtD
Asenapine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.53e-05	0.000768	CcSEcCtD
Asenapine—Fatigue—Gliclazide—type 2 diabetes mellitus	9.51e-05	0.000767	CcSEcCtD
Asenapine—Nausea—Glipizide—type 2 diabetes mellitus	9.49e-05	0.000764	CcSEcCtD
Asenapine—Vomiting—Glimepiride—type 2 diabetes mellitus	9.48e-05	0.000763	CcSEcCtD
Asenapine—Hypotension—Valsartan—type 2 diabetes mellitus	9.47e-05	0.000763	CcSEcCtD
Asenapine—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.45e-05	0.000761	CcSEcCtD
Asenapine—Constipation—Gliclazide—type 2 diabetes mellitus	9.44e-05	0.00076	CcSEcCtD
Asenapine—Tremor—Losartan—type 2 diabetes mellitus	9.41e-05	0.000759	CcSEcCtD
Asenapine—Rash—Glimepiride—type 2 diabetes mellitus	9.4e-05	0.000757	CcSEcCtD
Asenapine—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.39e-05	0.000756	CcSEcCtD
Asenapine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.38e-05	0.000756	CcSEcCtD
Asenapine—Rash—Sitagliptin—type 2 diabetes mellitus	9.37e-05	0.000755	CcSEcCtD
Asenapine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.36e-05	0.000754	CcSEcCtD
Asenapine—Headache—Glimepiride—type 2 diabetes mellitus	9.34e-05	0.000752	CcSEcCtD
Asenapine—Headache—Sitagliptin—type 2 diabetes mellitus	9.31e-05	0.00075	CcSEcCtD
Asenapine—Anaemia—Losartan—type 2 diabetes mellitus	9.29e-05	0.000748	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.24e-05	0.000744	CcSEcCtD
Asenapine—Agitation—Losartan—type 2 diabetes mellitus	9.23e-05	0.000744	CcSEcCtD
Asenapine—Hypertension—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000743	CcSEcCtD
Asenapine—Angioedema—Losartan—type 2 diabetes mellitus	9.18e-05	0.00074	CcSEcCtD
Asenapine—Insomnia—Valsartan—type 2 diabetes mellitus	9.17e-05	0.000739	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.13e-05	0.000736	CcSEcCtD
Asenapine—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.09e-05	0.000732	CcSEcCtD
Asenapine—Shock—Metformin—type 2 diabetes mellitus	9.08e-05	0.000732	CcSEcCtD
Asenapine—CYP3A4—liver—type 2 diabetes mellitus	9.08e-05	0.00338	CbGeAlD
Asenapine—Insomnia—Orlistat—type 2 diabetes mellitus	9.06e-05	0.00073	CcSEcCtD
Asenapine—Malaise—Losartan—type 2 diabetes mellitus	9.06e-05	0.00073	CcSEcCtD
Asenapine—Anxiety—Irbesartan—type 2 diabetes mellitus	9.06e-05	0.00073	CcSEcCtD
Asenapine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.06e-05	0.00073	CcSEcCtD
Asenapine—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.05e-05	0.00073	CcSEcCtD
Asenapine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.04e-05	0.000728	CcSEcCtD
Asenapine—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.04e-05	0.000728	CcSEcCtD
Asenapine—Somnolence—Valsartan—type 2 diabetes mellitus	9.01e-05	0.000726	CcSEcCtD
Asenapine—Syncope—Losartan—type 2 diabetes mellitus	9.01e-05	0.000726	CcSEcCtD
Asenapine—Leukopenia—Losartan—type 2 diabetes mellitus	8.99e-05	0.000725	CcSEcCtD
Asenapine—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.94e-05	0.00072	CcSEcCtD
Asenapine—CYP2D6—liver—type 2 diabetes mellitus	8.93e-05	0.00333	CbGeAlD
Asenapine—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.93e-05	0.000719	CcSEcCtD
Asenapine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	8.92e-05	0.000719	CcSEcCtD
Asenapine—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.89e-05	0.000716	CcSEcCtD
Asenapine—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000716	CcSEcCtD
Asenapine—Nausea—Glimepiride—type 2 diabetes mellitus	8.85e-05	0.000713	CcSEcCtD
Asenapine—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.83e-05	0.000712	CcSEcCtD
Asenapine—Nausea—Sitagliptin—type 2 diabetes mellitus	8.82e-05	0.000711	CcSEcCtD
Asenapine—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.82e-05	0.000711	CcSEcCtD
Asenapine—Asthenia—Glyburide—type 2 diabetes mellitus	8.82e-05	0.000711	CcSEcCtD
Asenapine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.75e-05	0.000705	CcSEcCtD
Asenapine—Fatigue—Valsartan—type 2 diabetes mellitus	8.74e-05	0.000704	CcSEcCtD
Asenapine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.71e-05	0.000702	CcSEcCtD
Asenapine—Mental disorder—Ramipril—type 2 diabetes mellitus	8.67e-05	0.000699	CcSEcCtD
Asenapine—Constipation—Valsartan—type 2 diabetes mellitus	8.67e-05	0.000699	CcSEcCtD
Asenapine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.65e-05	0.000697	CcSEcCtD
Asenapine—Fatigue—Orlistat—type 2 diabetes mellitus	8.64e-05	0.000696	CcSEcCtD
Asenapine—Hypotension—Metformin—type 2 diabetes mellitus	8.63e-05	0.000695	CcSEcCtD
Asenapine—Malnutrition—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000694	CcSEcCtD
Asenapine—Shock—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000691	CcSEcCtD
Asenapine—Arthralgia—Losartan—type 2 diabetes mellitus	8.55e-05	0.000689	CcSEcCtD
Asenapine—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.55e-05	0.000689	CcSEcCtD
Asenapine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000689	CcSEcCtD
Asenapine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	8.53e-05	0.000687	CcSEcCtD
Asenapine—Anxiety—Losartan—type 2 diabetes mellitus	8.52e-05	0.000687	CcSEcCtD
Asenapine—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000685	CcSEcCtD
Asenapine—Rash—Bromocriptine—type 2 diabetes mellitus	8.48e-05	0.000683	CcSEcCtD
Asenapine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.47e-05	0.000682	CcSEcCtD
Asenapine—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.44e-05	0.00068	CcSEcCtD
Asenapine—Headache—Bromocriptine—type 2 diabetes mellitus	8.42e-05	0.000679	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.41e-05	0.000678	CcSEcCtD
Asenapine—Dry mouth—Losartan—type 2 diabetes mellitus	8.37e-05	0.000674	CcSEcCtD
Asenapine—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000667	CcSEcCtD
Asenapine—Dyspnoea—Metformin—type 2 diabetes mellitus	8.23e-05	0.000663	CcSEcCtD
Asenapine—Somnolence—Metformin—type 2 diabetes mellitus	8.21e-05	0.000661	CcSEcCtD
Asenapine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.2e-05	0.000661	CcSEcCtD
Asenapine—Hypotension—Irbesartan—type 2 diabetes mellitus	8.14e-05	0.000656	CcSEcCtD
Asenapine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.13e-05	0.000655	CcSEcCtD
Asenapine—Dyspepsia—Metformin—type 2 diabetes mellitus	8.13e-05	0.000655	CcSEcCtD
Asenapine—Tremor—Ramipril—type 2 diabetes mellitus	8.07e-05	0.00065	CcSEcCtD
Asenapine—Shock—Losartan—type 2 diabetes mellitus	8.07e-05	0.00065	CcSEcCtD
Asenapine—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.04e-05	0.000648	CcSEcCtD
Asenapine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.03e-05	0.000647	CcSEcCtD
Asenapine—Tachycardia—Losartan—type 2 diabetes mellitus	8e-05	0.000645	CcSEcCtD
Asenapine—Nausea—Bromocriptine—type 2 diabetes mellitus	7.99e-05	0.000643	CcSEcCtD
Asenapine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.97e-05	0.000642	CcSEcCtD
Asenapine—Fatigue—Metformin—type 2 diabetes mellitus	7.96e-05	0.000641	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.94e-05	0.00064	CcSEcCtD
Asenapine—Asthenia—Gliclazide—type 2 diabetes mellitus	7.92e-05	0.000638	CcSEcCtD
Asenapine—Agitation—Ramipril—type 2 diabetes mellitus	7.92e-05	0.000638	CcSEcCtD
Asenapine—Constipation—Metformin—type 2 diabetes mellitus	7.9e-05	0.000636	CcSEcCtD
Asenapine—Angioedema—Ramipril—type 2 diabetes mellitus	7.87e-05	0.000634	CcSEcCtD
Asenapine—Vomiting—Glyburide—type 2 diabetes mellitus	7.81e-05	0.00063	CcSEcCtD
Asenapine—Malaise—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000626	CcSEcCtD
Asenapine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.77e-05	0.000626	CcSEcCtD
Asenapine—Rash—Glyburide—type 2 diabetes mellitus	7.75e-05	0.000624	CcSEcCtD
Asenapine—Somnolence—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000624	CcSEcCtD
Asenapine—Dermatitis—Glyburide—type 2 diabetes mellitus	7.74e-05	0.000624	CcSEcCtD
Asenapine—Syncope—Ramipril—type 2 diabetes mellitus	7.73e-05	0.000623	CcSEcCtD
Asenapine—Leukopenia—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000621	CcSEcCtD
Asenapine—Headache—Glyburide—type 2 diabetes mellitus	7.7e-05	0.00062	CcSEcCtD
Asenapine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.67e-05	0.000618	CcSEcCtD
Asenapine—Hypotension—Losartan—type 2 diabetes mellitus	7.66e-05	0.000617	CcSEcCtD
Asenapine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.57e-05	0.00061	CcSEcCtD
Asenapine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.52e-05	0.000606	CcSEcCtD
Asenapine—Fatigue—Irbesartan—type 2 diabetes mellitus	7.51e-05	0.000605	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.47e-05	0.000602	CcSEcCtD
Asenapine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.47e-05	0.000602	CcSEcCtD
Asenapine—Convulsion—Ramipril—type 2 diabetes mellitus	7.46e-05	0.000601	CcSEcCtD
Asenapine—Constipation—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.0006	CcSEcCtD
Asenapine—Insomnia—Losartan—type 2 diabetes mellitus	7.42e-05	0.000598	CcSEcCtD
Asenapine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.38e-05	0.000595	CcSEcCtD
Asenapine—Arthralgia—Ramipril—type 2 diabetes mellitus	7.33e-05	0.000591	CcSEcCtD
Asenapine—Dyspnoea—Losartan—type 2 diabetes mellitus	7.31e-05	0.000589	CcSEcCtD
Asenapine—Anxiety—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000589	CcSEcCtD
Asenapine—Nausea—Glyburide—type 2 diabetes mellitus	7.3e-05	0.000588	CcSEcCtD
Asenapine—Dizziness—Gliclazide—type 2 diabetes mellitus	7.3e-05	0.000588	CcSEcCtD
Asenapine—Somnolence—Losartan—type 2 diabetes mellitus	7.29e-05	0.000587	CcSEcCtD
Asenapine—Asthenia—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000586	CcSEcCtD
Asenapine—Dyspepsia—Losartan—type 2 diabetes mellitus	7.22e-05	0.000582	CcSEcCtD
Asenapine—Asthenia—Orlistat—type 2 diabetes mellitus	7.19e-05	0.000579	CcSEcCtD
Asenapine—Dry mouth—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000578	CcSEcCtD
Asenapine—Fatigue—Losartan—type 2 diabetes mellitus	7.07e-05	0.00057	CcSEcCtD
Asenapine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.03e-05	0.000567	CcSEcCtD
Asenapine—Vomiting—Gliclazide—type 2 diabetes mellitus	7.02e-05	0.000565	CcSEcCtD
Asenapine—Constipation—Losartan—type 2 diabetes mellitus	7.01e-05	0.000565	CcSEcCtD
Asenapine—Rash—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000561	CcSEcCtD
Asenapine—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.95e-05	0.00056	CcSEcCtD
Asenapine—Shock—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000557	CcSEcCtD
Asenapine—Headache—Gliclazide—type 2 diabetes mellitus	6.91e-05	0.000557	CcSEcCtD
Asenapine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000556	CcSEcCtD
Asenapine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000555	CcSEcCtD
Asenapine—Tachycardia—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000553	CcSEcCtD
Asenapine—Dizziness—Valsartan—type 2 diabetes mellitus	6.7e-05	0.00054	CcSEcCtD
Asenapine—Dizziness—Orlistat—type 2 diabetes mellitus	6.63e-05	0.000534	CcSEcCtD
Asenapine—Asthenia—Metformin—type 2 diabetes mellitus	6.62e-05	0.000534	CcSEcCtD
Asenapine—Hypotension—Ramipril—type 2 diabetes mellitus	6.57e-05	0.000529	CcSEcCtD
Asenapine—Nausea—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000528	CcSEcCtD
Asenapine—Vomiting—Valsartan—type 2 diabetes mellitus	6.45e-05	0.000519	CcSEcCtD
Asenapine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000517	CcSEcCtD
Asenapine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000516	CcSEcCtD
Asenapine—Rash—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000515	CcSEcCtD
Asenapine—Dermatitis—Valsartan—type 2 diabetes mellitus	6.39e-05	0.000515	CcSEcCtD
Asenapine—Vomiting—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000513	CcSEcCtD
Asenapine—Insomnia—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000512	CcSEcCtD
Asenapine—Headache—Valsartan—type 2 diabetes mellitus	6.35e-05	0.000512	CcSEcCtD
Asenapine—Rash—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000509	CcSEcCtD
Asenapine—Dermatitis—Orlistat—type 2 diabetes mellitus	6.31e-05	0.000509	CcSEcCtD
Asenapine—Headache—Orlistat—type 2 diabetes mellitus	6.28e-05	0.000506	CcSEcCtD
Asenapine—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000505	CcSEcCtD
Asenapine—Asthenia—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000504	CcSEcCtD
Asenapine—Somnolence—Ramipril—type 2 diabetes mellitus	6.25e-05	0.000504	CcSEcCtD
Asenapine—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.19e-05	0.000499	CcSEcCtD
Asenapine—Dizziness—Metformin—type 2 diabetes mellitus	6.11e-05	0.000492	CcSEcCtD
Asenapine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000489	CcSEcCtD
Asenapine—Fatigue—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000488	CcSEcCtD
Asenapine—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.04e-05	0.000487	CcSEcCtD
Asenapine—Nausea—Valsartan—type 2 diabetes mellitus	6.02e-05	0.000485	CcSEcCtD
Asenapine—Constipation—Ramipril—type 2 diabetes mellitus	6.01e-05	0.000484	CcSEcCtD
Asenapine—Nausea—Orlistat—type 2 diabetes mellitus	5.95e-05	0.00048	CcSEcCtD
Asenapine—Asthenia—Losartan—type 2 diabetes mellitus	5.88e-05	0.000474	CcSEcCtD
Asenapine—Vomiting—Metformin—type 2 diabetes mellitus	5.87e-05	0.000473	CcSEcCtD
Asenapine—Rash—Metformin—type 2 diabetes mellitus	5.82e-05	0.000469	CcSEcCtD
Asenapine—Dermatitis—Metformin—type 2 diabetes mellitus	5.82e-05	0.000469	CcSEcCtD
Asenapine—Headache—Metformin—type 2 diabetes mellitus	5.78e-05	0.000466	CcSEcCtD
Asenapine—Dizziness—Irbesartan—type 2 diabetes mellitus	5.76e-05	0.000464	CcSEcCtD
Asenapine—Vomiting—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000446	CcSEcCtD
Asenapine—Rash—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000443	CcSEcCtD
Asenapine—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.49e-05	0.000442	CcSEcCtD
Asenapine—Nausea—Metformin—type 2 diabetes mellitus	5.48e-05	0.000442	CcSEcCtD
Asenapine—Headache—Irbesartan—type 2 diabetes mellitus	5.46e-05	0.00044	CcSEcCtD
Asenapine—Dizziness—Losartan—type 2 diabetes mellitus	5.42e-05	0.000437	CcSEcCtD
Asenapine—Vomiting—Losartan—type 2 diabetes mellitus	5.21e-05	0.00042	CcSEcCtD
Asenapine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000417	CcSEcCtD
Asenapine—Nausea—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000417	CcSEcCtD
Asenapine—Rash—Losartan—type 2 diabetes mellitus	5.17e-05	0.000417	CcSEcCtD
Asenapine—Dermatitis—Losartan—type 2 diabetes mellitus	5.17e-05	0.000416	CcSEcCtD
Asenapine—Headache—Losartan—type 2 diabetes mellitus	5.14e-05	0.000414	CcSEcCtD
Asenapine—Asthenia—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000406	CcSEcCtD
Asenapine—Nausea—Losartan—type 2 diabetes mellitus	4.87e-05	0.000392	CcSEcCtD
Asenapine—Dizziness—Ramipril—type 2 diabetes mellitus	4.65e-05	0.000375	CcSEcCtD
Asenapine—Vomiting—Ramipril—type 2 diabetes mellitus	4.47e-05	0.00036	CcSEcCtD
Asenapine—Rash—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000357	CcSEcCtD
Asenapine—Dermatitis—Ramipril—type 2 diabetes mellitus	4.43e-05	0.000357	CcSEcCtD
Asenapine—Headache—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000355	CcSEcCtD
Asenapine—Nausea—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000337	CcSEcCtD
Asenapine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.21e-06	1.19e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Asenapine—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.19e-06	1.18e-05	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.19e-06	1.17e-05	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.19e-06	1.17e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.19e-06	1.17e-05	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.18e-06	1.17e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.18e-06	1.16e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.17e-06	1.16e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.17e-06	1.15e-05	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	1.15e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.17e-06	1.15e-05	CbGpPWpGaD
Asenapine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.17e-06	1.15e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.16e-06	1.15e-05	CbGpPWpGaD
Asenapine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.16e-06	1.14e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.15e-06	1.13e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.15e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.15e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.15e-06	1.13e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.15e-06	1.13e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.14e-06	1.13e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.14e-06	1.13e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.14e-06	1.12e-05	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.14e-06	1.12e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.14e-06	1.12e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.13e-06	1.11e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.12e-06	1.1e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.12e-06	1.1e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.12e-06	1.1e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.12e-06	1.1e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.12e-06	1.1e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.11e-06	1.1e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.11e-06	1.09e-05	CbGpPWpGaD
Asenapine—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	1.09e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.1e-06	1.09e-05	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.1e-06	1.08e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.1e-06	1.08e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.1e-06	1.08e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-06	1.08e-05	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.09e-06	1.07e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.09e-06	1.07e-05	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.09e-06	1.07e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.08e-06	1.07e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-06	1.06e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.08e-06	1.06e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-06	1.05e-05	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-06	1.05e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.07e-06	1.05e-05	CbGpPWpGaD
Asenapine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.06e-06	1.04e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.06e-06	1.04e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.06e-06	1.04e-05	CbGpPWpGaD
Asenapine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.06e-06	1.04e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.05e-06	1.04e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.05e-06	1.03e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.05e-06	1.03e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.04e-06	1.03e-05	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.03e-06	1.02e-05	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.03e-06	1.01e-05	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.03e-06	1.01e-05	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.03e-06	1.01e-05	CbGpPWpGaD
Asenapine—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.03e-06	1.01e-05	CbGpPWpGaD
Asenapine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.03e-06	1.01e-05	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.02e-06	1e-05	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.02e-06	1e-05	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.01e-06	9.98e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.01e-06	9.98e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.01e-06	9.93e-06	CbGpPWpGaD
Asenapine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	9.93e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-06	9.92e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.01e-06	9.92e-06	CbGpPWpGaD
Asenapine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.01e-06	9.91e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1e-06	9.88e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1e-06	9.87e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1e-06	9.84e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.98e-07	9.82e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	9.95e-07	9.79e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.93e-07	9.78e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.91e-07	9.75e-06	CbGpPWpGaD
Asenapine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.88e-07	9.72e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.82e-07	9.66e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.79e-07	9.63e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.77e-07	9.61e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	9.76e-07	9.6e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.73e-07	9.57e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	9.71e-07	9.55e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	9.64e-07	9.48e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.6e-07	9.45e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	9.55e-07	9.4e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.55e-07	9.4e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	9.52e-07	9.37e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	9.51e-07	9.35e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.5e-07	9.35e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.5e-07	9.35e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	9.48e-07	9.32e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.45e-07	9.3e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	9.44e-07	9.29e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.43e-07	9.28e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.42e-07	9.27e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	9.38e-07	9.23e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.35e-07	9.2e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.34e-07	9.19e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	9.33e-07	9.18e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.33e-07	9.18e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.31e-07	9.17e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.25e-07	9.1e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.24e-07	9.09e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.22e-07	9.07e-06	CbGpPWpGaD
Asenapine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.18e-07	9.03e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	9.18e-07	9.03e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	9.17e-07	9.02e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.16e-07	9.02e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.16e-07	9.01e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.15e-07	9.01e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.15e-07	9e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	9.11e-07	8.96e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.1e-07	8.96e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.1e-07	8.95e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.04e-07	8.89e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.04e-07	8.89e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.01e-07	8.87e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.97e-07	8.83e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.97e-07	8.82e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.92e-07	8.77e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	8.86e-07	8.72e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.85e-07	8.71e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.84e-07	8.7e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.79e-07	8.65e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	8.78e-07	8.63e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	8.73e-07	8.59e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.72e-07	8.58e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.71e-07	8.57e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	8.69e-07	8.55e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.69e-07	8.55e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.62e-07	8.49e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.6e-07	8.46e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.55e-07	8.42e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.53e-07	8.39e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	8.51e-07	8.37e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.51e-07	8.37e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.49e-07	8.35e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	8.48e-07	8.35e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.47e-07	8.33e-06	CbGpPWpGaD
Asenapine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.47e-07	8.33e-06	CbGpPWpGaD
Asenapine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.46e-07	8.32e-06	CbGpPWpGaD
Asenapine—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.4e-07	8.27e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.38e-07	8.24e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.35e-07	8.22e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.35e-07	8.22e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.34e-07	8.2e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.31e-07	8.18e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.26e-07	8.13e-06	CbGpPWpGaD
Asenapine—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.23e-07	8.09e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	8.22e-07	8.09e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.16e-07	8.03e-06	CbGpPWpGaD
Asenapine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.1e-07	7.97e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.07e-07	7.94e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.93e-07	7.8e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.92e-07	7.79e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.9e-07	7.77e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	7.83e-07	7.7e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.79e-07	7.67e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.79e-07	7.66e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.77e-07	7.65e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.76e-07	7.64e-06	CbGpPWpGaD
Asenapine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.73e-07	7.6e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.72e-07	7.6e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	7.68e-07	7.56e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	7.64e-07	7.51e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.64e-07	7.51e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.63e-07	7.5e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.62e-07	7.5e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.48e-07	7.36e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	7.44e-07	7.32e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	7.4e-07	7.28e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.31e-07	7.2e-06	CbGpPWpGaD
Asenapine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.29e-07	7.17e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.29e-07	7.17e-06	CbGpPWpGaD
Asenapine—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	7.25e-07	7.14e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.2e-07	7.09e-06	CbGpPWpGaD
Asenapine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.19e-07	7.08e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.1e-07	6.99e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.09e-07	6.97e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.07e-07	6.96e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.07e-07	6.96e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	7.04e-07	6.92e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.95e-07	6.84e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.95e-07	6.84e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.79e-07	6.68e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.76e-07	6.65e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	6.57e-07	6.47e-06	CbGpPWpGaD
Asenapine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.55e-07	6.45e-06	CbGpPWpGaD
Asenapine—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.49e-07	6.39e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	6.47e-07	6.37e-06	CbGpPWpGaD
Asenapine—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.41e-07	6.31e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.35e-07	6.25e-06	CbGpPWpGaD
Asenapine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.27e-07	6.17e-06	CbGpPWpGaD
Asenapine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.23e-07	6.13e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.23e-07	6.13e-06	CbGpPWpGaD
Asenapine—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.06e-07	5.97e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.96e-07	5.87e-06	CbGpPWpGaD
Asenapine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	5.89e-07	5.8e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.87e-07	5.77e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.86e-07	5.76e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.75e-07	5.65e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	5.71e-07	5.62e-06	CbGpPWpGaD
Asenapine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.5e-07	5.41e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.46e-07	5.37e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.46e-07	5.37e-06	CbGpPWpGaD
Asenapine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.41e-07	5.33e-06	CbGpPWpGaD
Asenapine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.4e-07	5.32e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.34e-07	5.25e-06	CbGpPWpGaD
Asenapine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.3e-07	5.22e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	4.99e-07	4.91e-06	CbGpPWpGaD
Asenapine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.93e-07	4.85e-06	CbGpPWpGaD
Asenapine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	3.84e-07	3.78e-06	CbGpPWpGaD
Asenapine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.25e-07	3.2e-06	CbGpPWpGaD
Asenapine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.51e-07	2.47e-06	CbGpPWpGaD
